Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation.
Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available. Gambro AB, headquartered in Stockholm, Sweden, is a global medical technology and healthcare company which manufactures dialysis products, operates dialysis clinics and supplies blood bank technology products.
The company had revenue of SKr 26.6 billion (US$3.6 billion) in fiscal 2004 and SKr 10.7 billion (US$1.4 billion) in the first nine months of 2005, with the latter significantly lower than in the 2004-period due to the company selling its Gambro Healthcare US operations to DaVita in October 2005. In 2004, this business generated revenue of SKr 14.1 billion. At the end of 2004, the company had almost 21,300 employees and, following the sale of its US healthcare operations, Gambro now has around 11,300 employees in 40 countries.
Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation.